ライフサイエンスコーパス: manufacturer

1 management decision(s) that are made by food manufacturer.

2 of the gun shot residue with respect to the manufacturer.

3 then submitted for technical analysis by the manufacturer.

4 ids and other small compounds added from the manufacturer.

5 fashion with nominal values provided by each manufacturer.

6 rest, and 19 (56%) received funding from the manufacturer.

7 f Labor; a device cost was obtained from the manufacturer.

8 ll 4.3 mm wide and 13 mm long, from the same manufacturer.

9 nown-to-be-genuine batch from the same named manufacturer.

10 tion of the smokeless powder with respect to manufacturer.

11 f other tested SPT solutions depended on the manufacturer.

12 ing instructions and cutoffs provided by the manufacturer.

13 solutions varied remarkably depending on the manufacturer.

14 on depending on both the bottle position and manufacturer.

15 ariability and then were stratified by assay manufacturer.

16 10(5)-fold lower than those reported by the manufacturer.

17 ance values, even between lots from the same manufacturer.

18 the presence of formulations from two other manufacturers.

19 holds, application of confirmation step, and manufacturers.

20 h 2016, reference mining, and pharmaceutical manufacturers.

21 cificities, thresholds, test variations, and manufacturers.

22 t 7 among PZ lesions at 3 T in data from two manufacturers.

23 ailers in Madrid and information provided by manufacturers.

24 nge test were used for comparing means among manufacturers.

25 s) biennially by using information from food manufacturers.

26 ose most suited for theoreticians and column manufacturers.

27 erest for scientists, food or pharmaceutical manufacturers.

28 sultations were initiated with major vaccine manufacturers.

29 ssociation between drug prices and number of manufacturers.

30 sults were lower than those disclosed by the manufacturers.

31 eller-Hinton agar (MHA) from three different manufacturers.

32 harmaceutical preparations made by different manufacturers.

33 r the production of anion exchange resins by manufacturers.

34 embolism stocking styles made by 4 different manufacturers.

35 itions of these parameters differ among CPAP manufacturers.

36 distributed to Australasian food and grocery manufacturers.

37 h 2016, reference mining, and pharmaceutical manufacturers.

38 s of cleaning in place systems (CIP) of food manufacturers.

39 vely associated with the number of available manufacturers.

40 the rate tested in clinical trials for some manufacturers.

41 umina is one of the largest genotyping array manufacturers.

42 position could offer opportunities for dairy manufacturers.

43 the cutoff levels suggested by the test kit manufacturers.

44 in peptides, and 1 for EMA, from 5 different manufacturers), 2 HLA-DQ2/DQ8 tests from 2 manufacturers

45 antation for device upgrade, malfunction, or manufacturer advisory (OR, 1.354; 95% CI, 1.196-1.533),

46 vent of platform technologies offers vaccine manufacturers an opportunity to develop new vaccines fas

47 Manufacturer analyses revealed a case of premature pacem

48 ise agreement between sequences while fixing manufacturer and field strength (n = 8).

49 references, and obtained data from the HBAT manufacturer and from the Centers for Disease Control an

50 dose (change in R(2) = 8%-32%), followed by manufacturer and iterative reconstruction (change in R(2

51 Engine calibration effects are manufacturer and model specific; emission trends for NOx

52 ercial standard was purchased from a Chinese manufacturer and purified (>98%).

53 closely corresponded to those quoted by the manufacturer and those obtained by the reported spectrop

54 ing reports needs to be standardized between manufacturers and AHIFlow should be used to describe res

55 will take considerable efforts by both food manufacturers and consumers and will likely require a na

56 n in red rice products provided by different manufacturers and formulated in various dosage forms.

57 The top 15 companies were all pharmaceutical manufacturers and paid dermatologists $28.7 million, rep

58 and their underlying principles by equipment manufacturers and pulmonary function laboratories can im

59 ional changes on the part of the pump-system manufacturers and pump users might reduce Pb exposure, t

60 imum dose per treatment are set by fungicide manufacturers and regulators at a level that provides ef

61 y Health Canada in 2007 instructing the food manufacturers and restaurants to limit TFAs in foods hav

62 ces in gepotidacin disk results between disk manufacturers and some agar types and also with potassiu

63 ected libraries purchased from two different manufacturers and that the fate of the "biased sequences

64 ng the gaps among material scientist, dental manufacturer, and clinical provider.

65 ntation-based methods (SEG1, provided by the manufacturer, and SEG2, a method with atlas-based suscep

66 resonance (MR) imaging among readers, imager manufacturers, and field strengths.

67 t manufacturers), 2 HLA-DQ2/DQ8 tests from 2 manufacturers, and histopathology findings from the refe

68 collaboration with drug regulators, vaccine manufacturers, and the private sector for immunization-r

69 aining three, a different CT unit of another manufacturer (Aquilion One) was used.

70 Diagnostic microbiology manufacturers are betting that robotics will be used for

71 vailable algorithms released by the major CT manufacturers are described.

72 Vaccine manufacturers are expected to develop sensitive assays t

73 changes in fatty acid composition that food manufacturers are likely to have made to avoid declaring

74 Cocoa manufacturers are producing novel products increasing po

75 Allergen manufacturers argue that offering a comprehensive panel

76 cies), the Entrez gene2go table, and various manufacturers' array annotation files.

77 NIRS could be used by chocolate manufacturers as a routine method to sort cocoa samples

78 ers (F1 and F2, respectively) from a Spanish manufacturer, as well as between F1 and F2 and two non-a

79 an orange concentrate, from a Spanish juice manufacturer, as well as in commercial orange juices and

80 ed phantom following the National Electrical Manufacturers Association (NEMA) IQ protocol.

81 were performed using the National Electrical Manufacturers Association 2007 image-quality phantom.

82 A National Electrical Manufacturers Association image-quality phantom was scan

83 urements proposed by the National Electrical Manufacturers Association NU 4 protocols were performed

84 e characterized with the National Electrical Manufacturers Association NU-2 2012 standards.

85 A National Electrical Manufacturers Association NU2 quality phantom was used f

86 e was measured using the National Electrical Manufacturers Association NU2-2012 methodology.

87 re measured based on the National Electrical Manufacturers Association NU2-2012 procedures.

88 hole-body system using a National Electrical Manufacturers Association quality-standard phantom.

89 t metrics modeled on the National Electrical Manufacturers Association standard for integral uniformi

90 ding to NU 2-2007 of the National Electrical Manufacturers Association.

91 ging scans of a modified National Electrical Manufacturers Association/International Electrotechnical

92 types (used in commercial aviation) from two manufacturers at thrust levels ranging from idle to take

93 iver biopsy and MRI (scanners from different manufacturers, at 1.5T or 3T).

94 consistency in antibody assignments between manufacturers (AUC > 0.9) and suggested optimal cutoffs

95 rgenic foods to guide a rational approach by manufacturers based on all publically available valid or

96 ermined by Etest and BMD using two different manufacturers (BBL and Difco) of cation-adjusted Mueller

97 5473 fresh cells from an automotive battery manufacturer before the cell-screening process.

98 e in the median NADAC price or the number of manufacturers between 2013 and 2016.

99 of irradiation) or supplied by a commercial manufacturer (bulk vial eluted from a generator).

100 at low cost and can be used not only by food manufacturers but also by regulatory agencies for better

101 oned partnering with a multinational vaccine manufacturer, but the target price and opportunity costs

102 ion in biotechnology-grade rHSA from various manufacturers by monitoring the degradation of adenosine

103 nks to standardization, parts from different manufacturers can be used in combination with each other

104 FEDs will be a more viable display option if manufacturers can increase the product's expected viewin

105 e surrogate in vitro assay, and decided that manufacturers can label a HDM allergen extract as having

106 Sometimes, the manufacturers claim antioxidant capacities that may not

107 Of the manufacturer-claimed organisms, 100% (64/64) and 92.2% (

108 We reviewed the ingredients and manufacturer claims of 11 ocular nutritional supplements

109 uct were collected from the product page and manufacturer claims.

110 ry LAAC procedure requires the presence of a manufacturer clinical specialist and for procedural para

111 lemented published literature with data from manufacturers' clinical trial registries and US Food and

112 ting government-protected monopolies to drug manufacturers, combined with coverage requirements impos

113 verall stable between 2013 and 2016, reduced manufacturer competition was associated with increased p

114 ncreases, and most, but not all, had limited manufacturer competition.

115 leic acid extraction control and an internal manufacturer control, GAPDH (glyceraldehyde-3-phosphate

116 dults (>/=25 kg) after administration of the manufacturers' currently recommended dose regimens.

117 have positive or negative findings based on manufacturer cut-off values.

118 a product group were indicative of batch- or manufacturer-dependent variation.

119 rovided for regulatory authorities, lighting manufacturers, designers, and engineers.

120 t by the patient's insurance company-not the manufacturer, distributor, or pharmacy-and is typically

121 by 90% or more, and 13 (16%) had 2 or fewer manufacturers during all 4 years.

122 of a downstream user, as CNTs from different manufacturers each had distinctive Pb isotope signatures

123 sted at one location using reagents from one manufacturer, each S. delphini strain tested positive fo

124 Furthermore, lowering of the WAC by the manufacturer (eg, a new product in the same class) may n

125 leware manufacturing factories in Taiwan (16 manufacturers, eight grinders, ten packers, and ten admi

126 f MIRP was substantially lower than da Vinci manufacturer estimates.

127 Test-retest repeatability across the various manufacturer, field strength, and pulse sequence combina

128 The overall ICC for all manufacturer, field strength, and sequence combinations

129 small amounts of variability between imager manufacturers, field strengths, and pulse sequences.

130 y liver stiffness measurements across imager manufacturers, field strengths, and pulse sequences.

131 ic PDFF measurements across all three imager manufacturer-field strength combinations also showed exc

132 While prices and the number of manufacturers for common oral antibiotics were overall s

133 for diagnostic tests, and to pharmaceutical manufacturers for drugs and biologics.

134 all US Food and Drug Administration-approved manufacturers for each formulation and strength in 2013

135 re and more attracting the attention of food manufacturers for their potential to transform food in f

136 compare changes in drug prices and number of manufacturers from 2013 to 2016.

137 le beta2-microglobulin rate increased in the manufacturers group.

138 ergoing high-level disinfection according to manufacturers' guidelines.

139 ons for telavancin have been restored, a new manufacturer has been secured, and reliable product supp

140 Some manufacturers have started producing shorter chain per-

141 f 495 adult employees of an automobile parts manufacturer in India.

142 p clinicians in the diagnosis of KC and lens manufacturers in designing suitable contact or intraocul

143 c and industrial partners, including vaccine manufacturers in developing countries.

144 and useful to both policy makers and vehicle manufacturers in developing future emission policy/techn

145 nstitutes and increasing capacity of vaccine manufacturers in emerging economies are helping drive fo

146 agnostic tool in all autopsies and to assist manufacturers in identifying potentially fatal device fa

147 next generation of vaccines, particularly by manufacturers in middle-to-high income countries, increa

148 though there has been progress by the device manufacturers in specifying device behavior in a magneti

149 PS, and they could be utilised by chocolate manufacturers in tropical countries.

150 he latest data acquisition software from the manufacturer, in use in some of our laboratories for nea

151 EHR systems will increase in value when manufacturers include integrated ASP tools and CDSSs tha

152 As financial risks to manufacturers increase even further with OPV cessation,

153 Urinary melamine concentrations in manufacturers increased sharply between pre- and post-sh

154 r presents msIQuant, a novel instrument- and manufacturer-independent quantitative mass spectrometry

155 t was then determined from ingredient lists, manufacturers' information and recipes.

156 proportion morphologically suitable (within manufacturers' instructions for use) for EVAR (EVAR suit

157 ypass this critical outstanding problem, two manufacturers introduced some low-calorie fats to substi

158 Six of 33 (18.2%) PAS and 20 of 171 (11.7%) manufacturer/investigator-initiated postmarket studies w

159 al premarket, pivotal, FDA-required PAS, and manufacturer/investigator-initiated postmarket studies,

160 33 (11.5%) FDA-required PAS, and 171 (59.8%) manufacturer/investigator-initiated postmarket studies.

161 FDA-required postapproval studies [PAS]; or manufacturer/investigator-initiated); premarket or postm

162 using filtered back projection (FBP) and two manufacturers' IR techniques, each at two strengths (mod

163 An FDS operated as intended by the manufacturer is safer than a TSF, but without adequate v

164 rs were modeled on those from two commercial manufacturers (LightSpeed VCT, GE Healthcare, Waukesha,

165 We also prospectively evaluated manufacturer-made BHI-V3/BHI-V4 biplates for screening o

166 Simultaneous screening for VISA/hVISA on manufacturer-made BHI-V4/BHI-V3 biplates is easy to stan

167 rn recognition analysis on multicentre/multi-manufacturer magnetic resonance spectroscopy data.

168 idal self-assembly has been utilized to help manufacturers make better paint with less cost.

169 culated by summing the squares of individual manufacturers' market shares, with higher values indicat

170 ations far exceed their related revenues and manufacturers may be forced to significantly limit their

171 Generic prescription drugs made by different manufacturers may vary in color or shape, and switching

172 le pulse sequences provided by the MR imager manufacturers (mDIXON Quant [Philips Healthcare], IDEAL

173 Recalibration of the manufacturers' methods for both FT4 and TSH has shown th

174 Due to generic drug manufacturer monopolization, flucytosine currently costs

175 The SPT solutions from different manufacturers (n = 3-5) for wheat flour, rye flour, soy,

176 for agreement between pulse sequences across manufacturers (n = 4) and field strengths (n = 5), respe

177 of vehicles equipped with original equipment manufacturer (OEM) diesel particulate filters (DPFs) in

178 ed with no filter, in-use original equipment manufacturer (OEM) filter, and two types of HECA filters

179 atients, vary significantly depending on the manufacturer of latanoprost.

180 conception of Homo sapiens as the exclusive manufacturer of specialised bone tools.

181 stimates of MIRP incidence attributed to the manufacturer of the da Vinci robot.

182 t concern, it may require the pharmaceutical manufacturer of the drug in question to conduct a postma

183 aried, depending upon the assay used and the manufacturer of the standards, with the degree of bias r

184 ed microcystin monitoring program or (2) the manufacturer of the testing kit by conducting additional

185 Manufacturers of glycoprotein biotherapeutics need to pr

186 increase in regulatory scrutiny that affects manufacturers of investigational drugs for early-phase c

187 d and Drug Administration (FDA) required all manufacturers of MPA products to propose risk evaluation

188 The manufacturers of the cdPCR and ddPCR systems available t

189 using the diagnostic algorithm from the same manufacturer on whose device the original data were coll

190 ld decide on the data to be presented by the manufacturer or the compounder and review those data, an

191 els with pump-system age, well depth, system manufacturer, or season of sample collection; only the c

192 try national regulatory authorities, vaccine manufacturers, partner organizations, and relevant units

193 This finding suggests that manufacturer practices and regulations, like the Consume

194 HPV testing followed the manufacturers' protocols.

195 ior in a magnetic field, and some MR imaging manufacturers provide maps of the "spatial gradients," t

196 The manufacturer provided vaccine and placebo in coded vials

197 ostoperative echocardiograms or preoperative manufacturer-provided charts, resulting in wide discrepa

198 SE approach was low and correlated well with manufacturer-provided PPM.

199 ions from US Food and Drug Administration or manufacturer recommendations for reprocessing.

200 conditions were set up corresponding to the manufacturers' recommendations and DIN 4734-1.

201 ng the concentration range observed with the manufacturers' recommended regimen.

202 at 0 (base fuel), 0.1-, 1-, and 10-fold the manufacturer-recommended concentration of 0.5 mL Envirox

203 superficial and deep vascular plexuses using manufacturer-recommended default settings are likely to

204 These reductions at the manufacturer-recommended doping concentration, however,

205 0 asymptomatic volunteers in accordance with manufacturer-recommended guidelines for CT lung cancer s

206 ence of reliability indices, when within the manufacturer-recommended limits, on VF classification ha

207 ity even when the SSI values were within the manufacturer-recommended limits.

208 ax, and lesion volume was assessed using the manufacturer-recommended reconstruction settings.

209 pecies and genus levels, respectively, using manufacturer-recommended score cutoffs.

210 0 the Institute of Medicine recommended that manufacturers reduce the amount of sodium in their produ

211 ealth technical agencies and donors, vaccine manufacturers, regulatory agencies, World Health Organiz

212 ts and establish active partnerships between manufacturers, relevant scientific societies, consumer o

213 ustry's uptake of the VITAL((R)) process, 25 manufacturers reported on factors that influenced the up

214 Manufacturers reported that 23% (95% CI 19-28) of produc

215 absolute differences between calculated and manufacturer-reported chlorination degrees were -0.9 to

216 onsumer products offer challenges to product manufacturers, risk managers, environmental regulators,

217 ws for transmission of data collected on one manufacturer's 12-lead ECG hardware/software into that o

218 ers (D) of the predicted refraction with the manufacturer's and optimized IOL constants.

219 Per the manufacturer's cut-point, the result of the second test

220 An IFN-gamma cutoff of 5.3 IU/ml or higher (manufacturer's cutoff is >/=0.35 IU/ml) yielded a conver

221 Using the manufacturer's cutoff value (>/=80 pg/ml), the sensitivi

222 Use of this test at the manufacturer's cutpoint in a population of 100000 with a

223 ficity of the most commonly used test at the manufacturer's cutpoint were 99% (95% CI, 97%-100%) and

224 1 paper using the manufacturer's data, published pore-size distribution me

225 Our library clearly outperformed the manufacturer's database that was obtained with the instr

226 The manufacturer's definition of QFT conversion results in a

227 ria for the pivotal trials referenced in the manufacturer's full prescribing information and 33% took

228 ot tested in a peer-reviewed trial for their manufacturer's ICDs.

229 was done using Zymogen Kit according to its manufacturer's instructions followed by amplifications w

230 to 11.62 muM, when prepared according to the manufacturer's instructions.

231 idcoronal dentin according to the respective manufacturer's instructions.

232 ion list, with optimal training according to manufacturer's instructions.

233 d postoperative refraction compared with the manufacturer's IOL constant, which may help improve the

234 y supplement in the morning according to the manufacturer's label.

235 sis, which was demonstrated on two different manufacturer's LC-MS/MS instruments.

236 Eleven of 14 licensed vaccines contained the manufacturer's listed vaccine seed strains, but 3 vaccin

237 The SFS-RR images were compared with the manufacturer's PSF-based reconstruction using the standa

238 tube 1 (TB1) or TB2 tested positive, per the manufacturer's recommendations, or if both TB1 and TB2 t

239 d, separately, by the Etest according to the manufacturer's recommendations.

240 d silver concentrations were at or above the manufacturer's recommended target for Legionella control

241 geing at low voltages, at and well below the manufacturer's recommended value.

242 of all included cases were imported into the manufacturer's software to generate en face images at th

243 anually measured by 2 ophthalmologists using manufacturer's software.

244 urs, and the results were analyzed using the manufacturer's software.

245 ic actinomycetes using both the MALDI-TOF MS manufacturer's supplied database(s) and a custom databas

246 The CIED interrogation, the manufacturer's technical analysis, and the final autopsy

247 ere statistically indistinguishable from the manufacturer's values.

248 n simply using thresholds recommended by the manufacturer, screening programs should choose threshold

249 Manufacturers' selling prices of various insulin formula

250 ing nonsterile amino acids due to a national manufacturer shortage.

251 acid components of PN was initiated due to a manufacturer shortage.

252 Manufacturers should provide more information about the

253 22 studies, one of two CT units of the same manufacturer (Somatom Definition or Somatom Definition F

254 Manufacturer-specific factors interacted with fast detec

255 mplex and unanticipated interactions between manufacturer-specific features and generic programming c

256 In clinical trials, manufacturer-specific, strategic programming of implanta

257 The LLOQ for each analyte agreed with manufacturer specifications except for MMP-1 and MMP-2 w

258 emarket approval (PMA) process, during which manufacturers submit clinical data demonstrating safety

259 thickness and volume were obtained from the manufacturer-supplied automated segmentation readouts.

260 rice compare at multiple pharmacies; (3) use manufacturer-supplied coupons to reduce out-of-pocket co

261 lower between-measurement variation than the manufacturer-supplied Spectralis software for the centra

262 But generics manufacturers that legally obtain a market monopoly can

263 and Drug Administration issued guidances to manufacturers that resulted in Center for Medicare and M

264 my; thus, it has been of great importance to manufacturers that the aroma of their food product is ch

265 collaboration between programme partners and manufacturers, the cessation of a supply market can be u

266 sweaters: four from one name-brand clothing manufacturer (three majority polyester fleece, and one n

267 ostic performance for AN were made at preset manufacturers' thresholds (range, 2.0-17.0 mug Hb/g fece

268 ed to rely on residual stocks including with manufacturers through to the last campaign to achieve it

269 evidence-based detection parameters from one manufacturer to another.

270 e insurer and may depend on rebates from the manufacturer to the distributor and to the insurer.

271 These new levels will enable manufacturers to apply credible precautionary labeling a

272 abel to include phosphorus but also for food manufacturers to consider alternatives to phosphate addi

273 more stringent guidelines for glucose meter manufacturers to evaluate the performance of blood gluco

274 o meat fractions, the possibility exists for manufacturers to fraudulently declare higher proportions

275 ceived, sufficient supply was awarded to two manufacturers to meet projected routine requirements.

276 c proliferation of precautionary labeling by manufacturers to mitigate the perceived risk from low-le

277 iral replication should greatly help vaccine manufacturers to produce high-yield reassortant vaccine

278 ate, and local regulation of ENDS; requiring manufacturers to register with the US Food and Drug Admi

279 Several incentives for manufacturers to sell alternative fuel vehicles (AFVs) h

280 The most important factor that allows manufacturers to set high drug prices is market exclusiv

281 FA overages are commonly added by manufacturers to some fortified products.

282 Oka/Biken working seed) from three different manufacturers (VariVax, GSK, and Biken) that 137 single-

283 by rapid PYR methods with products from four manufacturers was performed at two testing locations, an

284 sta beans with those declared on packages by manufacturers was verified.

285 of the labelling information declared by the manufacturers was within recommendations despite a degre

286 infant and toddler foods was collected from manufacturers' websites and stores from May to July 2015

287 itivity, although silica discs from the same manufacturer were used.

288 nal study, 29 automobiles from 15 automobile manufacturers were analyzed.

289 s from four batches of TPGS samples from two manufacturers were compared.

290 One hundred and thirty-seven Australasian manufacturers were contacted, and 59 questionnaires were

291 Manufacturers were exposed to the highest concentrations

292 derwent imaging with 3-T MR systems from two manufacturers were selected (data set A, n = 72; data se

293 ogy-approved phantom results between scanner manufacturers were similar.

294 al of 192 bottles from 32 bottle designs and manufacturers were tested.

295 Since FN response rates are ignored by the manufacturer while flagging a test as unreliable, clinic

296 We also surveyed three multinational manufacturers who supply influenza vaccines in the regio

297 od will be of value to other researchers and manufacturers wishing to study biofilm growth and remova

298 esulted in classification of the penultimate manufacturer with an accuracy of 89%.

299 ealth technical agencies and donors, vaccine manufacturers, World Health Organization and United Nati

300 h procedures have led to legal cases against manufacturers worldwide and to national inquiries about